Regional clinical hospital named after prof. S.V. Ochapovsky
Krasnodar, Russian Federation
Hospital in Krasnodar
Ulitsa 1 Maya, 167, Krasnodar, Krasnodar Krai, 350086
About Regional clinical hospital named after prof. S.V. Ochapovsky
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
Bayer
2
Pfizer
2
Clinical Trials at Regional clinical hospital named after prof. S.V. Ochapovsky
During the past decade, Regional clinical hospital named after prof. S.V. Ochapovsky conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on
average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
Non-interventional Study of Ocrelizumab in Participants With Relapsing or Primary Progressive Multiple Sclerosis
2018-11-12
2025-07-26
Active, not recruiting
1,700
Study to Gather Information About Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following a Recent Non Cardioembolic Ischemic Stroke Which Occurs When a Blood Clot Has Formed Somewhere in the Human Body (But Not in the Heart) Travelled to the Brain.
2020-06-15
2022-02-18
Completed
1,808
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)
2020-12-03
2029-09-06
Recruiting
699
Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
2021-03-24
2025-11-27
Recruiting
736
An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants
2021-08-18
2021-12-31
Completed
951
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Regional clinical hospital named after prof. S.V. Ochapovsky"
#1 collaborator was "Population Health Research Institute" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Regional clinical hospital named after prof. S.V. Ochapovsky
According to Clinical.Site data, the most researched conditions in "Regional clinical hospital named after prof. S.V. Ochapovsky" are
"Cardiovascular Disease" (2 trials), "Multiple Sclerosis" (2 trials), "Acute Non-cardioembolic Ischemic Stroke" (1 trials), "Chronic Kidney Disease" (1 trials) and "Relapsing Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Regional clinical hospital named after prof. S.V. Ochapovsky" in a lesser frequency.
Clinical Trials Intervention Types at Regional clinical hospital named after prof. S.V. Ochapovsky
Most popular intervention types in "Regional clinical hospital named after prof. S.V. Ochapovsky" are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Ocrelizumab" (2 trials), "bococizumab (PF-04950615)" (2 trials), "Antihistamine" (1 trials) and "BAY2433334" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Regional clinical hospital named after prof. S.V. Ochapovsky
The vast majority of trials in "Regional clinical hospital named after prof. S.V. Ochapovsky" are
7 trials for "All" genders.
Clinical Trials Status at Regional clinical hospital named after prof. S.V. Ochapovsky
Currently, there are NaN active trials in "Regional clinical hospital named after prof. S.V. Ochapovsky".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Regional clinical hospital named after prof. S.V. Ochapovsky,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Regional clinical hospital named after prof. S.V. Ochapovsky, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".